Investigation of the Effects of the Technology-based Cardiac Rehabilitation Program in Coronary Artery Patients

June 17, 2024 updated by: Dilara Saklica, Hacettepe University

Investigation of the Effects of Artificial Intelligence-supported and Technology-based Cardiac Rehabilitation Programs on Participation and Exercise Capacity in Coronary Artery Patients

This study was planned to investigate the effectiveness of technology-based and traditional cardiac rehabilitation programs in individuals with coronary artery disease.

Study Overview

Detailed Description

Cardiovascular diseases constitute one of the most critical health problems of today's society due to the loss of workforce, morbidity, mortality, and high hospital expenses.

This study was planned to investigate the effectiveness of technology-based and traditional cardiac rehabilitation programs in individuals with coronary artery disease.

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06100
        • Hacettepe University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with coronary artery disease
  • Access to the online program
  • Volunteering to participate in the research
  • Having an iOS or Android operating system compatible phone

Exclusion Criteria:

  • Having a musculoskeletal problem
  • Having uncontrolled hypertension
  • Having chronic heart failure (NYHA III-IV)
  • A history of acute coronary syndrome or surgical revascularization less than 12 months ago
  • More than 50% occlusion on the main coronary artery
  • Having arrhythmia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Physiotherapist Supervised Exercise Training Group
Physiotherapist supervised exercise training in patients with coronary artery disease
Exercise training for 12 weeks will be given by video talk accompanied by a physiotherapist.
Experimental: Exercise Training Tracking from Phone-app Group
Exercise training tracking from phone app in patients with coronary artery disease
Exercise training for 12 weeks will be given over the developed phone application.
Experimental: Control Group
General physical activity recommendations for home
The program will be consist of 12 weeks of physical activity recommendations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exercise Capacity
Time Frame: Baseline, after 12 weeks, after 24 weeks
Exercise capacity will be evaluated using the incremental shuttle walk test.
Baseline, after 12 weeks, after 24 weeks
Participation
Time Frame: after 12 weeks
Participation will be evaluated using the number of sessions attended.
after 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peripheral muscle strength
Time Frame: Baseline, after 12 weeks, after 24 weeks
Peripheral muscle strength will be evaluated using the dynamometer.
Baseline, after 12 weeks, after 24 weeks
Endothelial function
Time Frame: Baseline, after 12 weeks, after 24 weeks
The endothelial function will be evaluated using echocardiography. After a resting baseline, Brachial artery diameter will be recorded, the cuff used in blood pressure measurement will be inflated 25-50 mmHg above the systolic blood pressure value and maintain that pressure for 5 min. The brachial artery diameter will be measured again after the cuff is deflated.
Baseline, after 12 weeks, after 24 weeks
Healthy Living Habit Evaluation
Time Frame: Baseline, after 12 weeks, after 24 weeks
Healthy living habit evaluation will be evaluated using the Healthy Lifestyle Behaviors Scale-II.
Baseline, after 12 weeks, after 24 weeks
Health-Related Quality of Life
Time Frame: Baseline, after 12 weeks, after 24 weeks
Health-Related Quality of Life will be evaluated using the Myocardial Infarction Dimensional Assessment Scale (MIDAS).
Baseline, after 12 weeks, after 24 weeks
QoL
Time Frame: Baseline, after 12 weeks, after 24 weeks
Quality of life will be evaluated using the SF-36 Short Form.
Baseline, after 12 weeks, after 24 weeks
Maximal Effort Capacity
Time Frame: Baseline
Maximal effort capacity will be evaluated using a cardiovascular stress test.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Naciye Vardar-Yagli, PhD, Hacettepe University
  • Study Director: Hikmet Yorgun, PhD, Hacettepe University
  • Study Chair: Ahmet Hakan Ates, PhD, Hacettepe University
  • Study Chair: Deniz Yuce, PhD, Hacettepe University
  • Principal Investigator: Dilara Saklica, MSc, Hacettepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 7, 2022

Primary Completion (Actual)

May 1, 2024

Study Completion (Actual)

May 1, 2024

Study Registration Dates

First Submitted

February 19, 2022

First Submitted That Met QC Criteria

March 1, 2022

First Posted (Actual)

March 3, 2022

Study Record Updates

Last Update Posted (Actual)

June 18, 2024

Last Update Submitted That Met QC Criteria

June 17, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Clinical Trials on Physiotherapist supervised exercise training

Subscribe